Sales rise 13.17% to Rs 31.54 crore
Net Loss of Sun Pharma Advanced Research Company reported to Rs 68.40 crore in the quarter ended September 2022 as against net loss of Rs 55.14 crore during the previous quarter ended September 2021. Sales rose 13.17% to Rs 31.54 crore in the quarter ended September 2022 as against Rs 27.87 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales31.5427.87 13 OPM %-198.48-196.16 -PBDT-65.40-52.60 -24 PBT-68.40-55.14 -24 NP-68.40-55.14 -24Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content